Bone Marrow TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsGraft vs Host DiseaseTransplantation, AutologousWhole-Body IrradiationBone and BonesAnemia, AplasticTransplantation ConditioningHematopoietic Stem Cell TransplantationLeukemiaLiver TransplantationTransplantation ChimeraTissue DonorsGraft SurvivalBusulfanBone Marrow PurgingHistocompatibility TestingHematopoietic Stem CellsHistocompatibilityCyclophosphamideTransplantation, IsogeneicBone Marrow DiseasesKidney TransplantationRecurrenceHematopoiesisCombined Modality TherapyRadiation ChimeraMice, Inbred C57BLLeukemia, Myelogenous, Chronic, BCR-ABL PositiveBone Marrow ExaminationLeukemia, Myeloid, AcuteTreatment OutcomeTime FactorsImmunosuppressive AgentsRemission InductionHematologic NeoplasmsGraft RejectionPrecursor Cell Lymphoblastic Leukemia-LymphomaHepatic Veno-Occlusive DiseaseBone RemodelingBone Marrow NeoplasmsTransplantation ImmunologyLeukemia, MyeloidGraft vs Host ReactionAcute DiseaseRetrospective StudiesImmunosuppressionLymphoma, Non-HodgkinStem Cell TransplantationLymphocyte DepletionLeukocyte TransfusionHeart TransplantationSurvival AnalysisSevere Combined ImmunodeficiencyT-LymphocytesColony-Forming Units AssayChimeraMyelodysplastic SyndromesHLA AntigensLung TransplantationActuarial AnalysisHematologic DiseasesBone DensityCyclosporineLymphocyte TransfusionFollow-Up StudiesAntineoplastic Combined Chemotherapy ProtocolsNuclear FamilyCarmustineOrgan TransplantationSurvival RatePancytopeniaGraft vs Tumor EffectCell DifferentiationLeukocyte CountCytarabineGraft vs Leukemia EffectCytomegalovirus InfectionsBone ResorptionSpleenFatal OutcomeGranulocyte Colony-Stimulating FactorDisease-Free SurvivalMelphalanMice, Inbred BALB CLymphomaPrognosisEtoposideFlow CytometryMultiple MyelomaCells, CulturedHodgkin DiseaseAntigens, CD34InfectionMice, KnockoutCell TransplantationGranulocytesBone Neoplasms